Abstract
The Canadian Institutes of Health Research (CIHR) has recently developed a major strategic initiative in the areas of regenerative medicine and nanomedicine. The present article presents a preliminary analysis of nanomedicine funding at CIHR (2000-2005), using a moderately stringent definition of nanomedicine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Canadian Institutes of Health Research (June, 2003); http://www.cihr-irsc.gc.ca/e/16044.html
Canadian Institutes of Health Research (June, 2005); http://www.cihr-irsc.gc.ca/e/28268.html
Canadian Institutes of Health Research (January, 2006); http://www.cihr-irsc.gc.ca/e/29542.html Stem Cell Network (January, 2006); http://www.stemcellnet.ca/
Stem Cell Network (January, 2006); http://www.stemcellnet.ca/e/
Quirion, R., 2002, A Canadian experiment: INMHA. How to link up the brain via a virtual institute, Trends in Neuroscience, 25: 268-270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this paper
Cite this paper
MARCOTTE, E., QUIRION, R. (2006). A SUMMARY OF CANADIAN NANOMEDICINE RESEARCH FUNDING: STRENGTHS AND NEEDS. In: Dubowski, J.J., Tanev, S. (eds) Photon-based Nanoscience and Nanobiotechnology. NATO Science Series, vol 239. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5523-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5523-2_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5521-8
Online ISBN: 978-1-4020-5523-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)